HIV Nexus
A one-stop location for information across the HIV continuum, including up-to-date tools and guidelines for your practice, and educational materials for your patients
HIV/AIDS Resources for Healthcare Professionals
Despite the stigma that HIV/AIDS carry, modern medicine has made it possible for people with HIV to live long, healthy, and active lives.
Excerpt – CDC Updated PrEP Guidelines
December 8, 2021
Key revisions to the guideline include:
- A new recommendation for providers to inform all sexually active adults and adolescents about PrEP. This is intended to increase awareness of PrEP more broadly.
- A recommendation that, in addition to taking a very brief history to identify persons with indications for PrEP, providers prescribe PrEP to anyone who requests it, even if they do not report specific HIV risk behaviors. This recommendation is intended to make PrEP available to people who may be apprehensive about sharing potentially stigmatized HIV risk behaviors with their provider.
- A recommendation for F/TAF (Descovy) as an FDA-approved PrEP option for sexually active men and transgender women at risk of getting HIV, based on recent data showing its effectiveness for these populations.
- A new section on prescribing bimonthly intramuscular injections of cabotegravir (CAB) for sexually active men and women who could benefit from PrEP, pending FDA data review and potential regulatory action.
- Updated HIV testing recommendations that incorporate the latest and most effective methods for quickly detecting HIV infection among people using any PrEP medication.
Learn more about the CDC's updated PrEP Guidelines!
Research for Providers
Selected Clinical Trials About HIV/AIDS
NIH
The Invisible US Hispanic/Latino HIV Crisis: Addressing Gaps in the National Response
American Journal of Public Health
Disparities in HIV Care Among Hispanic/Latino Men and Women
American Journal of Managed Care
NIH experts call for accelerated research to address concurrent HIV and COVID-19 pandemics
NIH
Maintaining HIV care during the COVID-19 pandemic
The Lancet
COVID-19 in patients with HIV: clinical case series
The Lancet
HIV Prevention in the Hispanic Community: Sex, Culture, and Empowerment
SAGE Journals
The Efficacy of an HIV Risk Reduction Intervention for Hispanic Women
Springer Link
HIV Testing Beliefs in a Predominantly Hispanic Community Health Center During the Routine HIV Testing Era: Does English Language Ability Matter?
NIH
Ending the HIV epidemic in US Latinx sexual and gender minorities
The Lancet
Factors Associated with Lack of HIV Testing among Latino Immigrant and Black Patients at 4 Geographically and Demographically Diverse Emergency Departments
SAGE Journals
Adherence
eHealth to Enhance Treatment Adherence among Youth Living with HIV
Springer Link
Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges
Springer Link
The Role of Stigma Management in HIV Treatment Adherence
MDPI
Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
Dovepress
What is HIV/AIDS?
What Are HIV and AIDS?
HIV.gov
About HIV/AIDS
CDC
HIV & AIDS
Planned Parenthood
What are HIV and AIDS?
Avert
The Basics of HIV Prevention
NIH
Prevention of HIV/AIDS
Stanford Healthcare
Prevention HIV/AIDS
NHS
How can I prevent HIV?
Planned Parenhood
Treatment
AIDS & HIV: Symptoms, Treatment and Prevention
Live Science
HIV/AIDS
Mayo Clinic
HIV Treatment: The Basics
NIH
AIDS Treatment
University of California San Francisco
Fact Sheet: HIV Among Latinos
CDC
PrEP Coverage for Large C0-pays or Uninsured Patients
Copay cards for oral PrEP
Injectable PrEP Savings and Assistance
ViiVConnect Programs
Patient Advocate Foundation
HIV, AIDS Prevention
Good Days
HIV, AIDS Treatment & Prevention
Oral PrEP Assistance Program
Advancing Access
State PrEP Assistance Program
PREP/ PEP Access
Ready Set PrEP
Find Out If You Qualify to Enroll for Free PrEP Medications